Shore Capital Group Reiterates Buy Rating for ECO Animal Health Group (LON:EAH)

ECO Animal Health Group (LON:EAH)‘s stock had its “buy” rating reissued by equities research analysts at Shore Capital Group in a research report issued on Wednesday,London Stock Exchange reports.

ECO Animal Health Group Trading Up 5.8%

EAH traded up GBX 5.50 during trading on Wednesday, reaching GBX 101. The company had a trading volume of 32,832 shares, compared to its average volume of 61,948. The stock has a market cap of £67.76 million, a P/E ratio of 23.01 and a beta of -0.05. The business has a 50 day simple moving average of GBX 106.17 and a 200-day simple moving average of GBX 95.41. ECO Animal Health Group has a 52 week low of GBX 50 and a 52 week high of GBX 116.90. The company has a quick ratio of 2.14, a current ratio of 3.73 and a debt-to-equity ratio of 5.97.

About ECO Animal Health Group

ECO Animal Health is a world leader in animal health, developing and marketing branded veterinary pharmaceuticals globally, with expertise in antibiotics and vaccines for pigs and poultry. We have a maturing proprietary R&D pipeline.

Headquartered in the UK, with global offices including R&D and manufacturing, we have marketing authorisations in over 70 countries and employ over 200 people worldwide.

Our lead product, Aivlosin® is a proprietary, patented medication which is effective against both respiratory and intestinal diseases in pigs and poultry.